Celonic AG

At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

Cureline AG belongs to Cureline Group, precision medicine CRO of Californian origin and global reach. In 20 years of its history, Cureline Group became a best-in-class expert in oncology human sample validation studies (HBS biobanking), in vitro and animal testing. New venture: ATMP CDMO (EU).